Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.（IONS）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · IONS · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
142
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Ionis Pharmaceuticals, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
IONS 季度内部人买卖趋势
IONS 内幕交易卖出 · IONS 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · IONS CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
IONS 高管卖出股份 · IONS 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 1, 2026 | BERTHELSEN SPENCER R Director | Option | 8,000 | $195K | Form 4 |
| Jun 1, 2026 | BERTHELSEN SPENCER R Director | Sale | 8,000 | $605K | Form 4 |
| May 14, 2026 | Monia Brett P CEO · Director | Option | 3,220 | $105K | Form 4 |
| May 13, 2026 | Monia Brett P CEO · Director | Option | 1,316 | $43K | Form 4 |
| May 13, 2026 | Monia Brett P CEO · Director | Sale | 1,316 | $103K | Form 4 |
| May 14, 2026 | Monia Brett P CEO · Director | Sale | 3,220 | $253K | Form 4 |
| May 4, 2026 | LOSCALZO JOSEPH Director | Option | 16,000 | $1.04M⚡ | Form 4 |
| May 4, 2026 | LOSCALZO JOSEPH Director | Option | 12,000 | $722K | Form 4 |
| May 4, 2026 | LOSCALZO JOSEPH Director | Option | 16,000 | $686K | Form 4 |
| May 4, 2026 | LOSCALZO JOSEPH Director | Option | 10,321 | $424K | Form 4 |
| May 4, 2026 | LOSCALZO JOSEPH Director | Option | 12,000 | $481K | Form 4 |
| May 4, 2026 | LOSCALZO JOSEPH Director | Sale | 59,508 | $4.46M⚡ | Form 4 |
| May 4, 2026 | LOSCALZO JOSEPH Director | Option | 10,968 | $417K | Form 4 |
| May 4, 2026 | LOSCALZO JOSEPH Director | Sale | 17,781 | $1.34M⚡ | Form 4 |
| May 1, 2026 | KLEIN JOSEPH III Director | Option | 10,111 | $476K | Form 4 |
| May 1, 2026 | KLEIN JOSEPH III Director | Sale | 8,680 | $637K | Form 4 |
| May 1, 2026 | KLEIN JOSEPH III Director | Sale | 1,431 | $107K | Form 4 |
| Apr 28, 2026 | Baroldi Joseph EVP, Chief Business Officer | Sale | 1,626 | $117K | Form 4 |
| Apr 15, 2026 | PARSHALL B LYNNE Director | Sale | 4,466 | $340K | Form 4 |
| Apr 15, 2026 | PARSHALL B LYNNE Director | Sale | 534 | $41K | Form 4 |
| Apr 15, 2026 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Option | 12,226 | — | Form 4 |
| Apr 16, 2026 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Sale | 4,902 | $368K | Form 4 |
| Apr 15, 2026 | Birchler Brian EVP, Corp and Development Ops | Option | 1,875 | — | Form 4 |
| Apr 16, 2026 | Birchler Brian EVP, Corp and Development Ops | Sale | 973 | $73K | Form 4 |
| Apr 15, 2026 | Baroldi Joseph EVP, Chief Business Officer | Option | 10,837 | — | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 IONS 内幕交易
IONS 内幕交易
Ionis Pharmaceuticals, Inc.（IONS）内幕交易数据来源于公司内部人（包括LOSCALZO JOSEPH (Director), KLEIN JOSEPH III (Director), Devers Shannon L. (EVP, Chief Human Resources Ofc)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。IONS内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Ionis Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
IONS 内幕交易 · 5个问题Ionis Pharmaceuticals, Inc.（IONS）的内部人包括高管和董事，如LOSCALZO JOSEPH (Director), KLEIN JOSEPH III (Director), Devers Shannon L. (EVP, Chief Human Resources Ofc)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026